Professionals 737 results
Capabilities 89 results
Practice Area
Securities, M&A & Corporate Governance Litigation
Practice Area
Practice Area
Experience 515 results
Experience
|October 10, 2025
Winston Advises Vistria Affiliate in $136M IPO of Phoenix Education Partners
Experience
|September 29, 2025
Winston Advises PJT Partners in Beyond Meat’s $1.105 Billion Exchange Offer
Experience
|September 23, 2025
Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals
Insights & News 4,854 results
Sponsorship
|November 20, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers South Florida M&A Conference
Sponsorship
|November 12, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers Houston M&A Conference
False Claims Act Playbook
|October 30, 2025
|5 Min Read
On October 15, 2025, the United States District Court for the District of Nebraska (the Court) dismissed Pharos Capital Group and its related investment funds (Pharos Capital) from a qui tam or whistleblower suit brought under the antiretaliation provision of the False Claims Act (31 U.S.C. § 3730(h)) (the FCA), against Pharos Capital and Charter Health Care Group (Charter), a portfolio company of Pharos Capital.
Other Results 122 results
Site Content
What Is a Publicly Held Company?
Site Content
Site Content


